Statement Of Cash Flows [Abstract]
| Concept |
2020-01-01 to 2020-12-31 |
2019-01-01 to 2019-12-31 |
|---|---|---|
| Statement of cash flows [abstract] | ||
| Cash flows from (used in) operating activities [abstract] | ||
| Adjustments for deferred tax expense |
10,768
EUR
|
11,798
EUR
|
| Cash flows from (used in) operations before changes in working capital |
126,831
EUR
|
293,961
EUR
|
| Increase (decrease) in working capital |
77,885
EUR
|
49,347
EUR
|
| Adjustments for decrease (increase) in trade and other receivables |
38,360
EUR
|
30,502
EUR
|
| Adjustments for increase (decrease) in trade and other payables |
120,965
EUR
|
50,711
EUR
|
| Adjustments for gains (losses) on change in fair value less costs to sell, biological assets |
10,334
EUR
|
0
EUR
|
| Adjustments for undistributed profits of investments accounted for using equity method |
4,883
EUR
|
1,334
EUR
|
| Cash flows from (used in) investing activities [abstract] | ||
| Purchase of property, plant and equipment, intangible assets other than goodwill, investment property and other non-current assets |
668,760
EUR
|
244,009
EUR
|
| Proceeds from disposals of property, plant and equipment, intangible assets other than goodwill, investment property and other non-current assets |
5,046
EUR
|
153,000
EUR
|
| Cash flows from (used in) financing activities [abstract] | ||
| Proceeds from issue of bonds, notes and debentures |
131,691
EUR
|
414,479
EUR
|
| Repayments of bonds, notes and debentures |
37,500
EUR
|
34,000
EUR
|